Resources for coping with cancer during COVID-19. Learn More

I am interested in participating in a clinical trial – what’s next?

Presenter: Dr. Paul Toren
Original Date: June 20, 2019

Dr. Paul Toren discusses the clinical trial process from beginning to end. This includes how eligibility is decided, what it means to provide consent to participate, the benefits and risks of participation, and a discussion of the most common types of clinical trials. Dr. Toren also explains what types of healthcare professionals are involved in clinical trials and what their roles are in your care. This webinar is presented in collaboration with Q-CROC. For additional information on clinical trials, click here.

Dawn RichardsPaul Toren's Biography:

Dr. Toren completed medical school at Queen's University in Kingston, Ontario and his urology residency and a one-year clinical uro-oncology fellowship at the University of Toronto. Subsequently, he completed a two-year research fellowship at the Vancouver Prostate Centre at the University of British Columbia under the mentorship of Drs. Martin Gleave and Amina Zoubeidi. His research, which led to a PhD from the Experimental Medicine Program at the University of British Columbia, focused on molecular mechanisms of enzalutamide resistant prostate cancer. He currently holds a clinician-scientist position in the Department of Surgery at Laval University where he pursues his interests in translational prostate cancer research. His research focuses on understanding factors within the prostate cancer microenvironment, which may act as biomarkers or therapeutic targets to delay the development of treatment resistance.

About Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

Rock the Road Raffle 2021

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Canadian Cancer Society and Prostate Cancer Canada celebrate their amalgamation

February 3, 2020 (Toronto, ON) – On the eve of World Cancer Day, the Canadian Cancer Society (CCS) and Prostate Cancer Canada (PCC) have finalized their amalgamation.

1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.

Click here for news archive